Table. Baseline Characteristics of the Intention-to-Treat Population.
| Characteristic | No. (%) (N = 12) |
|---|---|
| Age, median (range), y | 44.8 (23.2-73.2) |
| Male sex | 8 (67) |
| White race | 12 (100) |
| BMI,a median (range), kg/m2 | 28.0 (19.4-44.6) |
| PRP subtype | |
| Classic adult (I) | 6 (50) |
| Atypical adult (II) | 5 (42) |
| Classic juvenile (III) | 1 (8) |
| PASI, median (range) | 24.8 (12.6-57.6) |
| Physician Global Assessment | |
| Clear (0) | 0 |
| Almost clear (1) | 0 |
| Mild (2) | 0 |
| Moderate (3) | 9 (75) |
| Severe (4) | 3 (25) |
| DLQI, median (range) | 19 (9-28) |
| Itch NRS score, median (range) | 7 (4-10) |
| Pain NRS score, median (range) | 6 (3-9) |
| Age at diagnosis, median (range), y | 43.7 (10.3-73.0) |
| Duration of symptoms prior to enrollment, median (range), mo | 11.9 (1.4-453.8) |
| Previous systemic therapy | |
| Treatment naive | 1 (8) |
| Prior systemic therapy | 11 (92) |
| Prior methotrexate | 6 (50) |
| Prior systemic retinoid | 7 (58) |
| Prior biologic therapy | 4 (33) |
Abbreviations: BMI, body mass index; DLQI, Dermatology Life Quality Index; NRS, numeric rating scale; PASI, Psoriasis Area and Severity Index; PRP, pityriasis rubra pilaris.
a
Calculated as weight in kilograms divided by height in meters squared.